| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.48 | 0.0005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |